Acute pulmonary embolism - risk-stratified pathway
PE pathway · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Suspected pulmonary embolism worked up on a risk-stratified pathway: clinical probability (Wells/PERC) guides D-dimer vs imaging, then haemodynamic stratification decides between thrombolysis, monitoring and simple anticoagulation.
Assessment
Investigations
- Clinical probability (Wells); PERC in low-risk to avoid testing
- D-dimer if low/intermediate probability; CTPA (or V/Q) to confirm
- Stratify: high-risk (shock) vs intermediate vs low (e.g. PESI/sPESI); echo/troponin
Management
- Resuscitate; oxygen; analgesia
- High-risk (haemodynamic instability): systemic thrombolysis (or embolectomy if contraindicated)
- Intermediate-risk: anticoagulate and monitor closely for deterioration
- Low-risk: anticoagulate (DOAC/LMWH); consider ambulatory care (sPESI 0)
- Anticoagulation choice per renal function/pregnancy/cancer; treat the cause
- Caution: confirm PE before thrombolysis unless peri-arrest
Drugs & doses
Anticoagulation (DOAC / LMWH)
Systemic thrombolysis (high-risk)
Oxygen / analgesia
Disposition
Per risk; admit or ambulatory.
Stratify PE by haemodynamics - shock means thrombolysis, intermediate-risk means anticoagulate and watch, and low-risk (sPESI 0) may go home on a DOAC.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.